Sclerostin inhibition increases bone mass and bone defect regeneration in rats with type 2 diabetes mellitus

Research output: Contribution to journalResearch articleContributedpeer-review

Contributors

Details

Original languageEnglish
Pages (from-to)S71-S72
JournalBone
Volume50
Issue numberSupl.1
Publication statusPublished - 2012
Peer-reviewedYes

External IDs

WOS 000304503500176

Keywords

Sustainable Development Goals

Library keywords